The Enhanced Tumor Specificity of TG6002, an Armed Oncolytic Vaccinia Virus Deleted in Two Genes Involved in Nucleotide Metabolism
2019 · Molecular Therapy — Oncolytics · 94 citations
https://doi.org/10.1016/j.omto.2019.03.005
P
Philippe Erbs
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
108
Papers
1.8K
Citations
24
h-index
41
i10-index
Philippe Erbs is an academic researcher from Transgene (France). The author has contributed to research in topics: Virus-based gene therapy research & Viral Infectious Diseases and Gene Expression in Insects & CAR-T cell therapy research. The author has an h-index of 24, co-authored 92 publications.
ORCID: 0000-0002-6810-4610Papers by this author
worksDeletion of Apoptosis Inhibitor F1L in Vaccinia Virus Increases Safety and Oncolysis for Cancer Therapy
2019 · Molecular Therapy — Oncolytics · 32 citations
https://doi.org/10.1016/j.omto.2019.06.004
Preclinical Evaluation of the Oncolytic Vaccinia Virus TG6002 by Translational Research on Canine Breast Cancer
2020 · Molecular Therapy — Oncolytics · 25 citations
https://doi.org/10.1016/j.omto.2020.08.020
Safety, biodistribution and viral shedding of oncolytic vaccinia virus TG6002 administered intravenously in healthy beagle dogs
2021 · Scientific Reports · 13 citations
https://doi.org/10.1038/s41598-021-81831-2
A Phase I Clinical Trial of Intrahepatic Artery Delivery of TG6002 in Combination with Oral 5-Fluorocytosine in Patients with Liver-Dominant Metastatic Colorectal Cancer
2025 · Clinical Cancer Research · 9 citations
https://doi.org/10.1158/1078-0432.ccr-24-2498
Pharmacokinetics and tolerance of repeated oral administration of 5-fluorocytosine in healthy dogs
2021 · BMC Veterinary Research · 5 citations
https://doi.org/10.1186/s12917-021-02927-5
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat